Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
Innovations in Viral Clearance
Mock Viruses, Plant Design, and Rational Testing
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
Top 10 European Biopharma Clusters
As Brexit Casts Uncertain Shadow, Continent’s Industry Continues Growth Trajectory
For full access to this article login to GEN Select now.
Synthetic Bio Not Yet Ready for the Market
Lab-Designed Calls and Pathways Take Genetic and Metabolic Engineering to Next Level
- In May of this year, the J. Craig Venter Institute (JCVI) announced it had created the first fully synthetic, self-replicating bacterial cell ( Mycoplasma nycoides JCVI-syn1.0). While this proof-of-concept demonstration of an “artificial life form” might raise justifiable fears about the dangers of unregulated or nefarious synthetic biology efforts, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.